A
NovoLipid, Inc Research Triangle Park Category: Pharmaceutical Preparations
|
Company representatives
Phone: 919 606 8185
Email: moc.dipilovon@ffohgnissomg
Michael Hackett, EVP and Chief Scientific Officer
Phone: 513 404 1552
Email: moc.laimg@ttekcah.ekim
Gregory Mossinghoff, owner
About NovoLipid, Inc
NovoLipid, Inc. is an oncology drug discovery company built on a proprietary technology platform invented at the University of North Carolina, Chapel
Products and Services
- Drug Discovery
Employees
2 to 4
Years In Business
14